Immune Thrombocytopenia, or ITP, is a condition that affects people in very different ways. Some people never need treatment, while others may need short-term or long-term support to manage bleeding or maintain a safe platelet count. This page explains the overall approach to treating ITP and what to expect before exploring individual treatment options.
Treatment decisions for ITP are guided by expert recommendations developed specifically for Australia and New Zealand. These guidelines help ensure that care is consistent, evidence‑based and aligned with local practice.
You can explore the guidelines here:
Adult Treatment Guidelines
Clear guidance on diagnosing and managing ITP in adults, including first-line, second-line, and longer-term treatment options.
Paediatric Treatment Guidelines
Specialised guidance for children and teens, including when treatment is needed, when watch and wait is appropriate and how to manage bleeding. These resources are designed to support conversations with your healthcare team and to help you understand the available treatment pathways.
ITP treatments fall into several broad categories. Your healthcare team will choose the approach that best fits your symptoms, platelet count, lifestyle and personal preferences.
Many people with ITP do not need treatment straight away. Regular check-ups and blood tests may be all that is required.
Used to quickly raise platelet levels or manage bleeding. These include corticosteroids and intravenous immunoglobulin (IVIg).
Used when ITP continues or when symptoms affect daily life. These include thrombopoietin receptor agonists (TPO-RAs), rituximab, and other medicines.
Used when bleeding is severe or urgent support is needed. These may include platelet transfusions, high-dose steroids or IVIg.
Splenectomy is rarely used today but may be considered in specific situations when other treatments have not worked.
ITP behaves differently from person to person. This is why two people with the same platelet count may have very different symptoms or treatment needs.
Treatment responses vary because:
Your healthcare team will help you understand what is typical for you and how your ITP may change over time.
ITP treatments are often described as first‑line, second‑line and third‑line. These terms explain the usual order in which treatments are tried, based on how quickly they work, how well they are tolerated and how long their effects last. This order is a guide only. Not every person will follow the same pathway, and your doctor may recommend a different approach based on your symptoms, platelet count, lifestyle and personal preferences.
It is also common for treatments from different categories to be used together. For example, a short course of steroids may be combined with IVIg, or a TPO RA may be used alongside another medicine. Your healthcare team will tailor your treatment plan to what works best for you.
First‑line treatments are usually offered when treatment is needed for the first time. They are chosen because they work quickly and are suitable for many people.
First‑line treatments include:
Second‑line treatments are used when first‑line treatments such as corticosteroids or IVIg have not worked well enough, when symptoms return, or when treatment is needed for longer than a few weeks. These options have the strongest evidence for effectiveness after first‑line therapy and are commonly used in Australia and New Zealand.
Second‑line treatments include:
These three options are the core second‑line treatments recommended in the ANZ guidelines. Your doctor will help you choose the option that best fits your lifestyle, preferences and medical needs.
If second line treatments are not suitable, not available or have not worked well enough, other medicines may be used to help maintain a safe platelet count or reduce bleeding. These options are sometimes called third line or “beyond second line” treatments.
These treatments are more individualised and may be considered when:
Other longer-term options may include:
Medicines that calm the immune system over time, such as:
These medicines may take weeks or months to work and are often used when other options are not suitable.
Such as danazol, used in carefully chosen situations.
Such as danazol, used in carefully chosen situations.
Access to new or emerging treatments through research studies, usually in specialist centres.
Your haematologist will tailor these options to your individual needs, taking into account your bleeding history, other health conditions, infection and clotting risks, and your personal preferences.
Not everyone with ITP needs treatment.
Treatment is usually recommended when there is significant bruising or bleeding, when platelet counts fall to a level that increases bleeding risk or when symptoms begin to affect daily life. Treatment may also be needed if you have a planned procedure or surgery, if support is required during pregnancy or birth or if platelet counts do not improve on their own.
For many people, the goal is not to reach a normal platelet count but to reach a safe level that prevents bleeding and allows them to live their lives comfortably.
Choosing a treatment is a partnership between you and your healthcare team. This approach is called shared decision making.
Your preferences matter. Some people prefer treatments that work quickly. Others prefer options with fewer side effects or less frequent dosing.
Learn more about each treatment, how it works and what to expect.
These pages provide clear, practical information to help you understand your options and feel confident in your treatment plan.
